Wir verwenden Cookies ausschließlich zu dem Zweck, technisch notwendige Funktionen wie das Login oder einen Warenkorb zu ermöglichen, oder Ihre Bestätigung zu speichern. Mehr Informationen zur Datenerhebung und -verarbeitung finden Sie in unserer Datenschutzerklärung.
Dr. Effie Habsha received her Bachelor of Science degree and earned her DDS degree from the University of Toronto. Upon graduation, she completed a one year General Practice Residency at Mount Sinai Hospital in Toronto, ON. Dr. Habsha received her Diploma in Prosthodontics and Master of Science degree, both from the University of Toronto. She is a Fellow of the Royal College of Dentists of Canada (RCDC) and is an examiner and Section Head for the Oral Examination in Prosthodontics for the RCDC. Dr. Habsha is an Adjunct Assistant Professor at the Department of Dentistry, Eastman Institute for Oral Health at the University of Rochester Medical Center. She has served as an Assistant Professor at the University of Toronto and currently instructs both at the undergraduate and graduate level in Prosthodontics at U of T. Dr. Habsha is a Professor at George Brown College of Applied Arts and Technology and is the On-staff Prosthodontist at MedCan clinic in Toronto. She holds an appointment as Staff Prosthodontist at Mount Sinai Hospital where she instructs the dental residents and is involved in various clinical research projects. Dr. Habsha is an Associate Fellow of the Academy of Prosthodontics and Greater New York Academy of Prosthodontics and a Fellow of The Pierre Fauchard Academy and holds memberships in numerous Prosthodontic organizations and societies. She lectures both nationally and internationally on various Prosthodontic topics and maintains a private practice limited to Prosthodontics and Implant Dentistry in Toronto.
Veranstaltungen
ISC 2023 – The 26th International Symposium on Ceramics
Simplicity Meets EstheticsJuni 8, 2023 — Juni 11, 2023Town and Country Resort, San Diego, Vereinigte Staaten von Amerika
Referenten: Wael Att, Diego Bechelli, Markus B. Blatz, Domenico Cascione, Gerard J. Chiche, Stephen J. Chu, Victor Clavijo, Florin Cofar, Iván Contreras Molina, Don Cornell, Lee Culp, Vincent Fehmer, Mirela Feraru, German O. Gallucci, Petra Gierthmühlen, Gustavo Giordani, David Guichet, Galip Gürel, Effrat Habsha, Hilal Kuday, Kenneth A. Malament, Adam J. Mieleszko, Ricardo Mitrani, Masayuki Okawa, Jacinthe M. Paquette, Joshua Polansky, Marta Revilla-León, Giuseppe Romeo, Irena Sailer, John Sorensen, Martina Stefanini, Taiseer Sulaiman, Douglas A. Terry, Van Thompson, George Tysowsky, Eric Van Dooren, Yu Zhang
Quintessence Publishing Co., Inc. USA
Zeitschriftenbeiträge dieses Autors
The International Journal of Prosthodontics, 5/2006
PubMed-ID: 17323728Seiten: 491-498, Sprache: EnglischDeLuca, Stephelynn / Habsha, Effrat / Zarb, George A.
Purpose: Recent studies implicate smoking as a significant factor in the failure of dental implants. The purpose of this long-term retrospective study was to evaluate the survival of Brånemark endosseous dental implants in relation to cigarette smoking.
Materials and Methods: The sample consisted of 464 consecutively treated completely and partially edentulous patients who had a total of 1852 implants placed between 1979 and 1999, and who were part of a surgical/prosthodontic prospective treatment outcomes study. The effect of cigarette smoking on implant survival in relation to the time of implant failure, gender, age, surgeon, date and site of implant placement, implant length and diameter, prosthesis design, and occlusal loading considerations was assessed in bivariate and multivariate survival analyses.
Results: The overall implant failure rate was 7.72%. Patients who were smokers at the time of implant surgery had a significantly higher implant failure rate (23.08%) than nonsmokers (13.33%). Multivariate survival analysis showed early implant failure to be significantly associated with smoking at the time of stage 1 surgery and late implant failure to be significantly associated with a positive smoking history. Short implants and implant placement in the maxilla were additional independent risk factors for implant failure.
Conclusion: Cigarette smoking should not be an absolute contraindication for implant therapy; however, patients should be informed that they are at a slightly greater risk of implant failure if they smoke during the initial healing phase following implant insertion or if they have a significant smoking history.